# Source:Dr. John Campbell, URL:https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg, language:en-UK

## Pandemic optimism, excess deaths pessimism
 - [https://www.youtube.com/watch?v=yPOEU1qCW_w](https://www.youtube.com/watch?v=yPOEU1qCW_w)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2022-09-03 00:00:00+00:00

UK, Zoe symptom study

https://health-study.joinzoe.com/data

Daily new cases = 106,548

Current symptomatic prevalence = 1,488,559

UK official data

https://coronavirus.data.gov.uk

Patients admitted, 4,124 down 14% (past 7 days)

With covid or for covid?

Deaths, 419, down 38% (past 7 days)

ONS latest

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights

W/E 23rd August, prevalence

1.64% in England (1 in 60 people)

1.56% in Wales (1 in 65 people) 

1.95% in Northern Ireland (1 in 50 people) 

1.82% in Scotland (1 in 55 people)

Reinfections within the omicron wave

14.6%

Alpha, 1.8%

Delta, 1%

Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants

https://www.nejm.org/doi/full/10.1056/NEJMc2209479?query=TOC&cid=NEJM%20eToc,%20September%201,%202022%20DM1402792_NEJM_Non_Subscriber&bid=1141953912

https://www.nejm.org/doi/suppl/10.1056/NEJMc2209479/suppl_file/nejmc2209479_appendix.pdf

Wuhan-Hu-1  55.7%

Alpha   58.8%

Delta   64.5%

BA.1 / BA.2  76.8% 

(UK, 84.4%)

Long covid

2.0 million people in private households in the UK (3.1%)

Of those

83% symptoms at least 12 weeks

45% at least one year

22% at least two years

Symptoms

Fatigue, 62%

Shortness of breath, 37%

Difficulty concentrating, 33%

Muscle ache, 31%

Symptoms adversely affected the day-to-day activities

1.5 million people, (73% of those with SRLC)

China, millions in Covid lockdown

https://www.theguardian.com/world/2022/aug/31/china-places-millions-into-covid-lockdown-again-as-economy-continues-to-struggle

China, cases, + 1,717 cases, majority asymptomatic

Sporadic cases around China

Southern cities of Shenzhen and Guangzhou

Northern port city of Dalian

Western metropolis of Chengdu to Shijiazhuang

Central Hebei province

Varying levels of restrictions, closure of venues and restaurants

Delayed school reopening

Foreign visitors, more than a week of quarantine hotels, sanitary conditions often poor

Masking and regular testing, close contacts forcibly transported to field hospitals

World Health Organization, China’s policy unsustainable

Anbound Research Center

President Xi Jinping’s government, 

Preventing the risk of economic stall should be the priority task

Moderna sues Pfizer and BioNTech 

https://www.washingtonpost.com/business/2022/08/26/moderna-pfizer-covid-lawsuit/?utm_campaign=wp_to_your_health&utm_medium=email&utm_source=newsletter&wpisrc=nl_tyh

https://www.documentcloud.org/documents/22266043-moderna-complaint?responsive=1&title=1

MODERNA SUES PFIZER AND BIONTECH FOR INFRINGING PATENTS CENTRAL TO MODERNA'S INNOVATIVE MRNA TECHNOLOGY PLATFORM
AUGUST, 26, 2022

https://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/default.aspx

Moderna Chief Legal Officer Shannon Thyme Klinger

We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission

Pfizer

We are surprised by the litigation given the Pfizer/BioNTech COVID-19 vaccine was based on BioNTech’s proprietary mRNA technology and developed by both BioNTech and Pfizer

